You are about to compete with a pharmacy.
The pen used to bring patients in. Now it walks them out. Wegovy is $199 a month direct from the manufacturer, and generics are landing. Everything you built around the prescription — the intake, the follow-up, the person who notices when something's off — is what your patient is actually paying for. Make sure it's what they're buying.
Self-pay, as of September 2026.
65% / year
GLP-1 dropout
~⅔ in 1 yr
regain after stopping
15 days
how far ahead we see it coming
The problem
Only one clinic model survives a cheaper pen.
Most clinics offering GLP-1 today run one of three models.
You sell the drug.
Your patient came for access. When the same pen costs less elsewhere, they leave — usually right before the turning point, when they needed you most.
You sell the consultation.
Your patient pays per visit. Between visits, nobody is watching. Side effects, plateaus, a skipped dose — you hear about it six weeks later, if at all. You have the relationship, but are missing the structure to keep it.
You sell the journey.
Your patient is held from the first week to the day the medication stops, through every phase. They stay because they're getting somewhere. You know where they are without asking.
Ew2health takes a clinic from the second model to the third - same doctors, same patients, but a program instead of a sequence of visits. If your model is the cheapest refill, we're probably not the right fit — and that's fine.
What the journey looks like
One patient. Four phases. We watch all of them.
Obesity care is a chronic-disease category. Patients move through four phases the literature treats as standard — and each one loses patients for a different reason.
Honeymoon
Adherence high, motivation fragile while the effect builds.
Ew2health
Daily adherence and side-effect signals, so nobody goes dark between visits.
Turning point
Dose increases, adherence dips, frustration sets in.
Ew2health
Predictive alerts flag the dip before the patient disappears.
Reward
Patients see impact; habits start to hold.
Ew2health
Behavior signals show which habits are solidifying, and who still needs you.
Post-medication
The phase where patients most need a next step, and most often don't have one.
Ew2health
Retention nudges and follow-on triggers keep the patient in your care.
Honeymoon
Adherence high, motivation fragile while the effect builds.
Ew2health
Daily adherence and side-effect signals, so nobody goes dark between visits.
Turning point
Dose increases, adherence dips, frustration sets in.
Ew2health
Predictive alerts flag the dip before the patient disappears.
Reward
Patients see impact; habits start to hold.
Ew2health
Behavior signals show which habits are solidifying, and who still needs you.
Post-medication
The phase where patients most need a next step, and most often don't have one.
Ew2health
Retention nudges and follow-on triggers keep the patient in your care.
Timing varies with starting BMI, age, dose response and biological sex. The phases follow a pattern; the calendar does not.
What your team gains
From chasing data to leading care.
Sinque does the reading in the background. When your team opens the dashboard on Monday, the question “who needs attention this week?” is already answered.
Always ready
Every weigh-in and behavioral signal processed before you log in.
Scientific read
Each patient interpreted the way a specialist would: doing well, struggling, or losing too fast.
Human decisions
Only the cases that need a clinical call reach your clinicians.
The financial picture
When the pen is the cheapest part of treatment, what's left to sell?
The journey. A patient who follows one program continuously loses more weight and keeps it off — and pays less overall than one who drops out, regains and restarts somewhere else. Better outcomes and better economics are the same decision.
Move the two sliders. See what one patient is worth to your clinic on a consult model versus a journey.
By month 6, the same 20 new patients a month earn your clinic $16,136 more every month on a journey than on consultations.
$6,000 vs $22,136 in month 6 · $69,000 vs $244,027 over the first year.
You're not asking your patient for more. You're offering the outcome — at lower cost to them overall.
Our own data. Real clinics.
The first weeks decide the outcome.
Findings from our own real-world data across partner clinics. Patients who build the monitoring habit in the first weeks of the program drop out less, stay longer, and lose more weight. And keep more of it off.
10×
more likely to drop out
When a patient doesn't build the monitoring habit in the first weeks.
n=241 (128 stayed vs 113 left) · 95% CI 5.2–19
3×
longer active in the program
5.7 vs 1.9 months enrolled. Every active month is recurring revenue for the clinic.
n=600 engaged vs 342 low engagement
4×
more patients reach ≥5% loss
42% vs 10% by month 6, comparing patients who weigh in 4+ times a week early against those under 2.
n=256 (4+/wk) vs 144 (<2/wk)
Patients with obesity in partner clinics. Observational data — association, not causation.
Your team — or ours
Your clinic. Your team — or ours.
Ew2health is the infrastructure. Who runs the program is your call.
In-house.
Your nutritionists, nurses or coordinators work the dashboard. One person can oversee hundreds of patients. You keep full clinical ownership.
Our certified network.
Vetted nutritionists and behavioral coaches, trained on the platform, operating under your brand. No hiring, no HR overhead, scale on demand.
Either way: a discovery call, your protocols mapped in, a one-hour team session, and your first patient enrolled together with us — live in weeks, not months.
What happens next
A 30-minute conversation. No deck.
Bring the medical director, the owner and whoever runs operations. We'll walk through what Ew2health looks like inside your workflow — your volume, your protocols, your team — and send a written fit analysis afterwards.
30 minutes
on Google Meet or Zoom
Your team welcome
Bring up to 5 stakeholders
Walk-away summary
We share a tailored fit analysis after the call
Or write to hello@ew2health.com